CD4 aptamer-siRNA chimeras (Immune Disease Institute)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCD4 aptamer-siRNA chimeras (Immune Disease Institute)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionC-C chemokine receptor type 5 antagonists
TargetsC-C chemokine receptor type 5
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmune Disease Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmune Disease Institute Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A